AJNR Am J Neuroradiol

1. SONI N, Ora M, Cai Y, Mark IT, et al
   A potential Adjunctive Role of 7T MRI and Amino-Acid PET in Localizing MRI-Occult Functional Pituitary Microadenomas: A Scoping Review.
   AJNR Am J Neuroradiol. 2026 Jun 4:ajnr.A9448. doi: 10.3174/ajnr.A9448.
   

   >> Share

   
   
2. LUAN H, Chen Z, Han X, Wang P, et al
   Neuronal Surface and Intracellular Antibodies in Mild Cognitive Impairment Due to Alzheimer Disease: Preserved Brain Metabolism on (18)F-FDG-PET.
   AJNR Am J Neuroradiol. 2026;47:1664-1671.
   

   >> Share

   
   

   
   Ann Nucl Med

3. CUI Y, Wang M, Liu Y, Liu Y, et al
   Local aggressiveness and prognostic prediction in desmoid-type fibromatosis: insights from (18)F-FDG PET/CT.
   Ann Nucl Med. 2026 Jun 1. doi: 10.1007/s12149-026-02221.
   

   >> Share

   
   
4. TSUSHIMA F, Koshiishi T, Shintaku T, Maruyama S, et al
   Utility of preoperative [(1)(8)F]FDG PET/CT for CT-guided biopsy polanning of large tumors: target adjustment and malignant yield with hotspot targeting.
   Ann Nucl Med. 2026 Jun 1. doi: 10.1007/s12149-026-02242.
   

   >> Share

   
   

   
   Brain

5. LI LL, Wang RZ, Wang Z, Hu H, et al
   Safety and short-term outcomes of lecanemab for Alzheimer's disease in China: a multicentre study.
   Brain. 2025 Nov 11:awaf427. doi: 10.1093.
   

   >> Share

   
   

   
   J Cereb Blood Flow Metab

6. HAHN A, Falb P, Murgas M, Klug S, et al
   EXPRESS: 18F]FDG functional PET revisited: a new perspective on the temporal dynamics of brain glucose metabolism.
   J Cereb Blood Flow Metab. 2026 Jun 1:271678X261455750.
   

   >> Share

   
   
7. EGGER K, Bozsak R, Aicher HDD, Sari H, et al
   EXPRESS: Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: A randomised [(18)F]FDG-PET Study.
   J Cereb Blood Flow Metab. 2026 Jun 1:271678X261454172.
   

   >> Share

   
   
8. CHUNG KJ, Jones T, Abdelhafez YG, Spencer BA, et al
   EXPRESS: Single-tracer [(18)F]FDG PET quantification of blood-brain barrier permeability and cerebral blood flow: Validation using dual-tracer PET.
   J Cereb Blood Flow Metab. 2026 May 31:271678X261458293.
   

   >> Share

   
   

   
   J Nucl Cardiol

9. KOUNGA C, Huck D, Sun A, Perillo A, et al
   Association of prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronary microvascular dysfunction: A pilot study.
   J Nucl Cardiol. 2026;59:102675.
   

   >> Share

   
   
10. LIMA BB, Dupont WD, Carr CM, Jahangir E, et al
    Effect of deep learning attenuation correction on accuracy of stress myocardial perfusion imaging.
    J Nucl Cardiol. 2026;59:102706.
    

    >> Share

    
    
11. ALWAN M, Al-Mallah MH, Al Rifai M
    Normal is not one size fits all: Age- and sex-specific reference values for myocardial blood flow and flow reserve with rubidium-82 positron emission tomogram.
    J Nucl Cardiol. 2026;59:102729.
    

    >> Share

    
    
12. NAKAMURA T, Tahara N, Koga Y, Yamagata Y, et al
    Right Ventricular Metabolic Adaptation to Afterload and Heterogeneous RV-Pulmonary Arterial Coupling in Pre-Capillary Pulmonary Hypertension: An FDG-PET/CMR Study.
    J Nucl Cardiol. 2026 Jun 3:102770. doi: 10.1016/j.nuclcard.2026.102770.
    

    >> Share

    
    

    
    J Nucl Med

13. VOLTIN CA, Flossdorf S, Kurch L, Winkelmann M, et al
    Risk Assessment in Large B-Cell Lymphoma Using Metabolic Tumor Volume: Real-World Data from a Multicenter Cohort of Patients Undergoing CAR T-Cell Therapy.
    J Nucl Med. 2026;67:871-877.
    

    >> Share

    
    
14. LI EJ, Kraya A, Costa-Pinheiro P, Scheuermann J, et al
    Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.
    J Nucl Med. 2026 Mar 19:jnumed.125.271476. doi: 10.2967/jnumed.125.271476.
    

    >> Share

    
    
15. LOLATTE K, Hess A, Willmann M, Strunk M, et al
    Deciphering Leukocyte Subpopulation Contributions to Ventricle Remodeling and Neuroinflammation After Myocardial Infarction Using Total-Body Molecular Imaging.
    J Nucl Med. 2026 Mar 19:jnumed.125.271451. doi: 10.2967/jnumed.125.271451.
    

    >> Share

    
    
16. HUBALEWSKA-DYDEJCZYK A, Decristoforo C, Mikolajczak R, Kolenc P, et al
    Improving the Somatostatin Receptor Status Assessment for Personalized and Precise Management of Neuroendocrine Neoplasms with the Use of a (99m)Tc-Radiolabeled Somatostatin Receptor Antagonist: The Final Results of the ERA PerMed TECANT Clinical Tria
    J Nucl Med. 2026;67:895-902.
    

    >> Share

    
    
17. NEISHABOURI A, Ghim M, Varli O, Ahmad AA, et al
    Molecular Imaging of Collagen Turnover in Myocardial Infarction.
    J Nucl Med. 2026 Mar 26:jnumed.125.271721. doi: 10.2967/jnumed.125.271721.
    

    >> Share

    
    
18. GIARRATANA AO, Jonaitis E, Przybelski RJ, Cody K, et al
    Longitudinal Evaluation of (18)F-MK-6240 Along the Alzheimer Disease Continuum.
    J Nucl Med. 2026;67:981-987.
    

    >> Share

    
    
19. BRENDEL M, Barthel H, Hoglinger GU
    Biologic Definition of Parkinson Disease: A Pivotal Role for Molecular Imaging.
    J Nucl Med. 2026;67:833-840.
    

    >> Share

    
    
20. URBAIN JC
    Nuclear Medicine in an Era of Exponential Growth.
    J Nucl Med. 2026;67:11A-12A.
    

    >> Share

    
    
21. BAUM RP, Zhao T, Jakobsson V, Greifenstein L, et al
    Fibroblast Activation Protein-Targeted Radiopharmaceutical Therapy Using (177)Lu-, (90)Y-, and (225)Ac-Labeled 3BP-3940: First Experience in 21 Different Advanced Malignancies.
    J Nucl Med. 2026;67:910-920.
    

    >> Share

    
    
22. KANG HG, Tashima H, Wakizaka H, Minamihisamatsu T, et al
    Sub-0.5-mm Resolution PET Versus Autoradiography: Comparison of mGluR1 Concentrations in Mouse Brain.
    J Nucl Med. 2026 Jun 4:jnumed.125.271600. doi: 10.2967/jnumed.125.271600.
    

    >> Share

    
    
23. SCHINDLER P, Brandt J, Bobe S, Krahling T, et al
    Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis.
    J Nucl Med. 2026 Jun 4:jnumed.125.271376. doi: 10.2967/jnumed.125.271376.
    

    >> Share

    
    
24. JIA KY, Kuten J, Jia HY, Bent EH, et al
    Diagnostic Value of Routine Delayed Pelvic Imaging for Patients with Biochemical Recurrence of Prostate Cancer Undergoing (68)Ga-PSMA PET/CT.
    J Nucl Med. 2026 Jun 4:jnumed.126.272009. doi: 10.2967/jnumed.126.272009.
    

    >> Share

    
    
25. MAZZIOTTA J, Czernin J
    From Architecture to Brain Imaging to Leader of a Major Academic Health System: John Mazziotta Talks with Johannes Czernin About an Evolving Career and Its Origins in Nuclear Medicine.
    J Nucl Med. 2026 Jun 4:jnumed.126.273012. doi: 10.2967/jnumed.126.273012.
    

    >> Share

    
    
26. PAULE A, Masson S, Rose Dite Modestine J, Kara N, et al
    Role of (18)F-PSMA PET/MRI in Prostate Cancer Recurrence After Prostatectomy.
    J Nucl Med. 2026 Jun 4:jnumed.126.272126. doi: 10.2967/jnumed.126.272126.
    

    >> Share

    
    

    
    Nucl Med Commun

27. YUE Y, Yu W, Jiang D, Tian Y, et al
    Cerebral metabolism mediates cognitive impairment in stroke-free atrial fibrillation patients: a mediation analysis using 18F-fluorodeoxyglucose PET/computed tomography.
    Nucl Med Commun. 2026 Jun 2. doi: 10.1097/MNM.0000000000002185.
    

    >> Share

    
    
28. KIM JY, Kim D, Kim GH, Yoon HJ, et al
    Effects of apolipoprotein E epsilon4 on amyloid deposition and relative cerebral perfusion in cognitively normal individuals: a dual-phase 18F-florbetaben PET study.
    Nucl Med Commun. 2026 Jun 2. doi: 10.1097/MNM.0000000000002186.
    

    >> Share

    
    
29. DONG Q, Zhou Q, Liu Y, Wang Q, et al
    Grading and detecting gastroenteropancreatic neuroendocrine neoplasms with dual-tracer ( 18 F-AlF-NOTA-octreotide/ 18 F-FDG) PET/CT: a metabolic parameter-based study.
    Nucl Med Commun. 2026 Jun 3. doi: 10.1097/MNM.0000000000002187.
    

    >> Share

    
    

    
    Nuklearmedizin

30. BUCHERT R, Meyer PT, Albert NL, Barthel H, et al
    German Society of Nuclear Medicine procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals (09/2025).
    Nuklearmedizin. 2026 Jun 2. doi: 10.1055/a-2821-9573.
    

    >> Share

    
    

    
    Phys Med Biol

31. CHO MJ, Shim HS, Kim S, Lee JS, et al
    GPDM: generation-prior diffusion model for accelerated direct attenuation and scatter correction of whole-body 18F-FDG PET.
    Phys Med Biol. 2026 Jun 3. doi: 10.1088/1361-6560/ae7798.
    

    >> Share

    
    

    
    PLoS One

32. ASIM N, Sirshar M, Khan MZ, Ejaz S, et al
    Tensor enhanced chest cancer classification via CNN and Vision Transformer models.
    PLoS One. 2026;21:e0348863.
    

    >> Share

    
    
33. CUCURACHI N, Fioroni F, Grassi E, Panico N, et al
    Real-time detection of extravasation events of diagnostic and therapeutic radiopharmaceuticals in oncology.
    PLoS One. 2026;21:e0350116.
    

    >> Share

    
    

    
    Semin Nucl Med

34. SOVANI B, Ravindra SG, Javidan C, Dehdashti F, et al
    (18)F-FDG -PET/CT in cardiac sarcoidosis: Diagnosis, therapy monitoring, and future directions.
    Semin Nucl Med. 2026 Jun 1:S0001-2998(26)00113.
    

    >> Share

    
    
35. SADEGHPOUR S, Saidi B, Sahafi P, Maleki F, et al
    Maximizing diagnostic yield: A systematic review and deep dive into PSMA PET scan protocol variations for prostate cancer.
    Semin Nucl Med. 2026 Jun 2:S0001-2998(26)00112.
    

    >> Share

    
    
36. AL-MALLAH MH
    The role of cardiac PET imaging in cardiac amyloidosis.
    Semin Nucl Med. 2026 May 30:S0001-2998(26)00118.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share